T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Snap-on
SNA
$21.1B
| $21.6M | ﹤0.01% |
74,538
+977
| +1% | +$269K |
|
|
RAPP
977
Rapport Therapeutics
RAPP
$2.29B
| $21.5M | ﹤0.01% |
1,047,408
-313,197
| -23% | -$6.73M |
|
978
Evertec
EVTC
$1.91B
| $21.3M | ﹤0.01% |
628,605
-22,017
| -3% | -$734K |
|
979
Molson Coors Class B
TAP
$7.75B
| $21.2M | ﹤0.01% |
367,945
+26,933
| +8% | +$1.44M |
|
980
Celanese
CE
$4.75B
| $20.9M | ﹤0.01% |
153,460
+16,409
| +12% | +$2.16M |
|
981
Universal Health Services
UHS
$10.2B
| $20.8M | ﹤0.01% |
90,961
-3,484
| -4% | -$751K |
|
982
PTC Therapeutics
PTCT
$6.06B
| $20.8M | ﹤0.01% |
559,746
-46,930
| -8% | -$1.57M |
|
983
A10 Networks
ATEN
$2B
| $20.7M | ﹤0.01% |
1,430,260
+88,852
| +7% | +$1.2M |
|
984
BridgeBio Pharma
BBIO
$16.4B
| $20.6M | ﹤0.01% |
810,465
-14,353
| -2% | -$377K |
|
985
Travel + Leisure Co
TNL
$4.58B
| $20.4M | ﹤0.01% |
443,003
+42,274
| +11% | +$1.87M |
|
986
Nordson
NDSN
$17.3B
| $20.3M | ﹤0.01% |
77,279
+506
| +0.7% | +$124K |
|
987
Hilton Grand Vacations
HGV
$3.49B
| $20.3M | ﹤0.01% |
557,646
+19,388
| +4% | +$751K |
|
988
Evolent Health
EVH
$471M
| $20.2M | ﹤0.01% |
715,905
-7,054
| -1% | -$182K |
|
989
AES
AES
$10.5B
| $20.1M | ﹤0.01% |
1,001,794
+1,940
| +0.2% | +$34.3K |
|
990
Advanced Drainage Systems
WMS
$11.3B
| $20M | ﹤0.01% |
127,478
-11,726
| -8% | -$1.83M |
|
991
Invesco Senior Loan ETF
BKLN
$6.76B
| $20M | ﹤0.01% |
950,000
+293,900
| +45% | +$6.18M |
|
992
EyePoint Inc
EYPT
$1.16B
| $19.9M | ﹤0.01% |
2,492,213
-10,158
| -0.4% | -$89.2K |
|
993
Gulfport Energy Corp
GPOR
$3.01B
| $19.8M | ﹤0.01% |
130,997
+1,318
| +1% | +$193K |
|
994
Huazhu Hotels Group
HTHT
$12.7B
| $19.8M | ﹤0.01% |
531,486
-36,819
| -6% | -$1.12M |
|
995
Badger Meter
BMI
$3.91B
| $19.7M | ﹤0.01% |
90,026
+26,789
| +42% | +$5.37M |
|
996
Liberty Energy
LBRT
$3.52B
| $19.6M | ﹤0.01% |
1,027,999
-42,051
| -4% | -$868K |
|
997
Chemed
CHE
$7.02B
| $19.6M | ﹤0.01% |
32,584
-28,346
| -47% | -$16.1M |
|
998
Bunge Global
BG
$21.5B
| $19.4M | ﹤0.01% |
200,451
-3,560
| -2% | -$364K |
|
999
Erie Indemnity
ERIE
$13.5B
| $19.3M | ﹤0.01% |
35,813
+26,244
| +274% | +$11.9M |
|
1000
Guardant Health
GH
$22.2B
| $19.3M | ﹤0.01% |
842,508
-533,166
| -39% | -$15.1M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.